Pharsight

Drugs that contain Insulin Susp Isophane Recombinant Human

1. Humulin N patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7291132 LILLY Medication dispensing apparatus with triple screw threads for mechanical advantage
Aug, 2024

(3 months from now)

Market Authorisation Date: 28 October, 1982

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

HUMULIN N family patents

Family Patents